Biomarker driven patient selection using Almac PNPLA3 & HSD17B13 Clinical Trial Assays
Time: 11:40 am
day: Conf Day 1 Track 2 AM
Details:
- Overview of the PNPLA3 & HSD17B13 Almac Clinical Trial Assays
- Assay Design & Analytical Specifications
- Implementation of the PNPLA3 or HSD17B13 assay in your MASH / MAFLD trial & expected performance
